|
Volumn 76, Issue 2, 2007, Pages 232-236
|
Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000
|
Author keywords
[No Author keywords available]
|
Indexed keywords
16 ALPHA BROMOEPIANDROSTERONE;
ANTIMALARIAL AGENT;
16 BROMOEPIANDROSTERONE;
16-BROMOEPIANDROSTERONE;
ANDROSTERONE;
DRUG DERIVATIVE;
IMMUNOLOGIC FACTOR;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONGENITAL HYPOTHYROIDISM;
CONTROLLED STUDY;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
FEVER;
HUMAN;
INJECTION SITE PAIN;
MALARIA;
MALE;
PARASITEMIA;
PLASMODIUM FALCIPARUM;
SIDE EFFECT;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ANIMAL;
BODY TEMPERATURE;
CLINICAL TRIAL;
DRUG EFFECT;
GROWTH, DEVELOPMENT AND AGING;
IMMUNOLOGY;
KAPLAN MEIER METHOD;
MALARIA FALCIPARUM;
PARASITOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
THAILAND;
HUMAN IMMUNODEFICIENCY VIRUS;
PLASMODIUM FALCIPARUM;
ADULT;
ANDROSTERONE;
ANIMALS;
BODY TEMPERATURE;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
KAPLAN-MEIERS ESTIMATE;
MALARIA, FALCIPARUM;
MALE;
PARASITEMIA;
PLASMODIUM FALCIPARUM;
THAILAND;
|
EID: 34047145991
PISSN: 00029637
EISSN: None
Source Type: Journal
DOI: 10.4269/ajtmh.2007.76.232 Document Type: Article |
Times cited : (12)
|
References (26)
|